They called it folklore for a thousand years. Modern biology just called it pharmacology.

In the Tang Dynasty — somewhere between 618 and 907 CE — Chinese physicians were prescribing a dark, bitter root for a specific cluster of symptoms: greying hair, thinning strands, the gradual diminishment of what they called "essence."

The root was Polygonum multiflorum. The texts that described its effects read, in the language of the era, like poetry.

Read in the language of 2026 molecular biology, they read like a clinical trial summary.

A new scientific review published in the Journal of Holistic Integrative Pharmacy has done what botanical science is increasingly doing to ancient traditions: it took a thousand years of accumulated clinical observation and asked, mechanism by mechanism, why it worked.

The answer is not a single pathway. It is four simultaneous ones — and every one of them maps onto what modern dermatology understands to be the actual drivers of androgenic alopecia.

The Biology

Four mechanisms. One ancient root.

Most pharmaceutical approaches to hair loss are single-target. Minoxidil opens blood vessels. Finasteride blocks one enzyme. The new drugs entering trials — clascoterone, PP405 — each address one specific pathway, with precision and limitations in equal measure.

Polygonum multiflorum appears to work differently. The review identified four distinct biological mechanisms operating at the same time. Which is either an extraordinary coincidence — or exactly why a thousand years of practitioners kept prescribing it.

The Pattern

Why this keeps happening — and what it means.

This is not the first time peer-reviewed science has arrived to confirm what traditional botanical medicine already knew.

Rosemary matched minoxidil in a randomised trial. Lavender produced a 46% increase in follicle count. Peppermint outperformed 3% minoxidil on multiple growth metrics. Cedarwood produced measurable alopecia areata improvement in a Scottish RCT. And now Polygonum multiflorum — used since the Tang Dynasty — shows four simultaneous molecular mechanisms that collectively address more of the biology of hair loss than any single currently-approved pharmaceutical.

Call it the botanical validation cycle: a plant used for centuries → dismissed as folklore by 20th century pharmaceutical science → redeemed by 21st century molecular biology that finally has the tools to explain the mechanism behind the observation.

Laritelle was built at the intersection of these two knowledge systems. Not because the brand predicted that peer-reviewed biology would eventually validate traditional botanical medicine — though it has, repeatedly — but because the certified aromatherapists and hair loss practitioners who formulate these products never accepted the premise that centuries of observed outcomes were less valid than a single six-month trial.

The Honest Context

What the research is — and what it still needs.

The review's authors are clear: more high-quality clinical trials are necessary to confirm these findings and determine optimal dosing and preparation.

There is also a processing caveat that matters: Polygonum multiflorum requires traditional preparation — a specific steaming and drying process — to achieve its beneficial profile while minimising hepatotoxicity risk associated with the raw root. The preparation method is not incidental. It is the difference between a medicine and a toxin.

This is precisely why formulation by trained practitioners — not marketing teams selecting attractive-sounding botanicals — determines whether a formula actually works.